| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.513 | 0.046 | 0.513 | Analgesic | 0.398 0.085 CID_154699580 | ||
| 0.294 | 0.036 | 0.301 | Tyrosine 3 hydroxylase inhibitor | 0.301 0.033 CID_154699580 | CID_154699580 | |
| 0.227 | 0.002 | 0.227 | 5 Hydroxytryptamine 1D agonist | 0.155 0.003 CID_154699580 | ||
| 0.288 | 0.074 | 0.384 | 5 Hydroxytryptamine release stimulant | 0.384 0.049 CID_154699580 | CID_154699580 | |
| 0.207 | 0.01 | 0.207 | 5 Hydroxytryptamine 1 agonist | 0.096 0.022 CID_154699580 | ||
| 0.226 | 0.032 | 0.261 | Cyclooxygenase inhibitor | 0.261 0.024 CID_154699580 | CID_154699580 | |
| 0.222 | 0.029 | 0.222 | 5 Hydroxytryptamine antagonist | 0.128 0.06 CID_154699580 | ||
| 0.273 | 0.089 | 0.282 | Nootropic | 0.282 0.084 CID_154699580 | CID_154699580 | |
| 0.197 | 0.015 | 0.208 | 5 Hydroxytryptamine agonist | 0.208 0.014 CID_154699580 | CID_154699580 | |
| 0.207 | 0.029 | 0.207 | 5 Hydroxytryptamine 2 antagonist | 0.129 0.054 CID_154699580 | ||
| 0.286 | 0.126 | 0.347 | Antiobesity | 0.347 0.088 CID_154699580 | CID_154699580 | |
| 0.181 | 0.043 | 0.203 | Cyclooxygenase 1 inhibitor | 0.203 0.033 CID_154699580 | CID_154699580 | |
| 0.239 | 0.107 | 0.36 | Insulysin inhibitor | 0.36 0.031 CID_154699580 | CID_154699580 | |
| 0.127 | 0.005 | 0.127 | 5 Hydroxytryptamine 1B agonist | 0.078 0.013 CID_154699580 | ||
| 0.116 | 0.004 | 0.126 | DNA helicase inhibitor | 0.126 0.004 CID_154699580 | CID_154699580 | |
| 0.118 | 0.008 | 0.118 | Neurokinin antagonist | |||
| 0.113 | 0.005 | 0.142 | Growth hormone secretagogue receptor agonist | 0.142 0.004 CID_154699580 | CID_154699580 | |
| 0.125 | 0.022 | 0.125 | 5 Hydroxytryptamine 1F antagonist | 0.069 0.051 CID_154699580 | ||
| 0.106 | 0.005 | 0.106 | Neurokinin 1 antagonist | |||
| 0.112 | 0.016 | 0.151 | Adrenaline uptake inhibitor | 0.151 0.009 CID_154699580 | CID_154699580 | |
| 0.121 | 0.024 | 0.142 | Metalloproteinase-9 inhibitor | 0.142 0.017 CID_154699580 | CID_154699580 | |
| 0.149 | 0.054 | 0.172 | Cyclooxygenase 2 inhibitor | 0.172 0.041 CID_154699580 | CID_154699580 | |
| 0.104 | 0.014 | 0.104 | 5 Hydroxytryptamine 6 antagonist | 0.084 0.021 CID_154699580 | ||
| 0.137 | 0.047 | 0.137 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.103 | 0.018 | 0.103 | CC chemokine 5 receptor agonist | 0.1 0.021 CID_154699580 | ||
| 0.151 | 0.079 | 0.178 | Anticoagulant | 0.178 0.062 CID_154699580 | CID_154699580 | |
| 0.084 | 0.016 | 0.084 | Glycine transporter inhibitor | 0.067 0.021 CID_154699580 | ||
| 0.102 | 0.035 | 0.102 | Alpha 2a adrenoreceptor antagonist | 0.074 0.054 CID_154699580 | ||
| 0.077 | 0.014 | 0.077 | Neurokinin 2 antagonist | |||
| 0.093 | 0.03 | 0.116 | Matrix metalloproteinase inhibitor | 0.116 0.021 CID_154699580 | CID_154699580 | |
| 0.257 | 0.197 | 0.321 | Calcium channel L-type activator | 0.321 0.14 CID_154699580 | CID_154699580 | |
| 0.118 | 0.06 | 0.118 | Alpha 2b adrenoreceptor antagonist | |||
| 0.097 | 0.039 | 0.129 | Metalloproteinase-2 inhibitor | 0.129 0.025 CID_154699580 | CID_154699580 | |
| 0.07 | 0.013 | 0.07 | Neurokinin 3 antagonist | |||
| 0.121 | 0.069 | 0.121 | Acetylcholine antagonist | 0.104 0.087 CID_154699580 | ||
| 0.122 | 0.072 | 0.122 | Cholinergic antagonist | 0.103 0.091 CID_154699580 | ||
| 0.072 | 0.025 | 0.084 | Matrix metalloproteinase 1 inhibitor | 0.084 0.019 CID_154699580 | CID_154699580 | |
| 0.21 | 0.165 | 0.23 | Antithrombotic | 0.23 0.144 CID_154699580 | CID_154699580 | |
| 0.189 | 0.144 | 0.189 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.097 | 0.053 | 0.097 | Alpha 2d adrenoreceptor antagonist | 0.091 0.067 CID_154699580 | ||
| 0.093 | 0.051 | 0.093 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.077 | 0.035 | 0.112 | 5 Hydroxytryptamine uptake inhibitor | 0.112 0.023 CID_154699580 | CID_154699580 | |
| 0.069 | 0.028 | 0.069 | Potassium channel (Ca-activated) blocker | 0.057 0.048 CID_154699580 | ||
| 0.133 | 0.092 | 0.133 | Cholinergic | |||
| 0.065 | 0.028 | 0.082 | Matrix metalloproteinase (membrane-type) inhibitor | 0.082 0.019 CID_154699580 | CID_154699580 | |
| 0.091 | 0.055 | 0.091 | Alpha 2 adrenoreceptor antagonist | |||
| 0.056 | 0.022 | 0.057 | Cholecystokinin antagonist | 0.057 0.02 CID_154699580 | CID_154699580 | |
| 0.056 | 0.025 | 0.056 | Nicotinic receptor alpha4 subunit antagonist | 0.046 0.042 CID_154699580 | ||
| 0.066 | 0.037 | 0.066 | Kallikrein 7 inhibitor | 0.064 0.042 CID_154699580 | ||
| 0.096 | 0.067 | 0.135 | Nitric-oxide synthase inhibitor | 0.135 0.03 CID_154699580 | CID_154699580 | |
| 0.068 | 0.043 | 0.068 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.106 | 0.084 | 0.106 | Acetylcholine muscarinic antagonist | |||
| 0.082 | 0.061 | 0.082 | Histamine H2 receptor antagonist | |||
| 0.075 | 0.055 | 0.087 | Nicotinic alpha4beta2 receptor antagonist | 0.087 0.043 CID_154699580 | CID_154699580 | |
| 0.042 | 0.024 | 0.042 | Substance P antagonist | |||
| 0.031 | 0.016 | 0.031 | 5 Hydroxytryptamine 6 agonist | 0.029 0.02 CID_154699580 | ||
| 0.09 | 0.075 | 0.09 | Alpha 2c adrenoreceptor antagonist | |||
| 0.08 | 0.066 | 0.081 | NMDA receptor antagonist | 0.081 0.064 CID_154699580 | CID_154699580 | |
| 0.077 | 0.063 | 0.077 | Acetylcholine M3 receptor agonist | |||
| 0.141 | 0.13 | 0.141 | Catenin beta inhibitor | |||
| 0.039 | 0.031 | 0.072 | Phenylethanolamine N methyltransferase inhibitor | 0.072 0.005 CID_154699580 | CID_154699580 | |
| 0.035 | 0.029 | 0.052 | Somatostatin 4 agonist | 0.052 0.014 CID_154699580 | CID_154699580 | |
| 0.019 | 0.015 | 0.019 | Progesterone receptor B antagonist | 0.018 0.016 CID_154699580 | ||
| 0.034 | 0.03 | 0.034 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.116 | 0.123 | 0.135 | MAP3K9 inhibitor | 0.135 0.085 CID_154699580 | CID_154699580 | |
| 0.035 | 0.042 | 0.068 | 5 Hydroxytryptamine 2C agonist | 0.068 0.016 CID_154699580 | CID_154699580 | |
| 0.028 | 0.036 | 0.036 | Somatostatin 5 agonist | 0.036 0.023 CID_154699580 | CID_154699580 | |
| 0.061 | 0.069 | 0.067 | Thrombin inhibitor | 0.067 0.06 CID_154699580 | CID_154699580 | |
| 0.123 | 0.132 | 0.13 | Amyloid beta aggregation inhibitor | 0.13 0.125 CID_154699580 | CID_154699580 | |
| 0.019 | 0.034 | 0.027 | Histamine H3 receptor agonist | 0.027 0.019 CID_154699580 | CID_154699580 | |
| 0.022 | 0.038 | 0.046 | Somatostatin agonist | 0.046 0.014 CID_154699580 | CID_154699580 | |
| 0.072 | 0.1 | 0.093 | Chemokine receptor antagonist | 0.093 0.07 CID_154699580 | CID_154699580 | |
| 0.032 | 0.063 | 0.048 | Metalloproteinase-3 inhibitor | 0.048 0.036 CID_154699580 | CID_154699580 | |
| 0.022 | 0.061 | 0.034 | Dipeptidyl peptidase II inhibitor | 0.034 0.021 CID_154699580 | CID_154699580 | |
| 0.007 | 0.051 | 0.014 | Somatostatin 2 agonist | 0.014 0.011 CID_154699580 | CID_154699580 | |
| 0.027 | 0.079 | 0.04 | Plasmin inhibitor | 0.04 0.039 CID_154699580 | CID_154699580 | |
| 0.209 | 0.264 | 0.254 | Cyclophilin D inhibitor | 0.254 0.208 CID_154699580 | CID_154699580 | |
| 0.012 | 0.069 | 0.022 | Motilin receptor agonist | 0.022 0.018 CID_154699580 | CID_154699580 | |
| 0.045 | 0.171 | 0.099 | Inducible nitric-oxide synthase inhibitor | 0.099 0.037 CID_154699580 | CID_154699580 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |